01 8CellCept
02 2Cellcept
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 676
2018 Revenue in Millions : 689
Growth (%) : -2
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 675
2019 Revenue in Millions : 731
Growth (%) : -8
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 637
2020 Revenue in Millions : 642
Growth (%) : -2
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 550
2021 Revenue in Millions : 637
Growth (%) : -14
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 456
2022 Revenue in Millions : 550
Growth (%) : -22
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2014 Revenue in Millions : -7.20%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2015 Revenue in Millions : 819
2014 Revenue in Millions : 793
Growth (%) : -3%
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2016 Revenue in Millions : 734
2015 Revenue in Millions : 777
Growth (%) : -6
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2017 Revenue in Millions : 739
2016 Revenue in Millions : 785
Growth (%) : -6
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2018 Revenue in Millions : 676
2017 Revenue in Millions : 704
Growth (%) : -4%
LOOKING FOR A SUPPLIER?